Stair-climbing
OtherShort bouts of moderate intensity stair-climbing
NCT Number: NCT03400774
This study aims to investigate the effect of moderate intensity stair-climbing bouts of various durations on postprandial blood glucose. Participants will perform a standard oral glucose tolerance test (OGTT) using 75g of dextrose and with fingerstick blood glucose measurements at baseline and every 15 minutes after consuming the drink for one hour. On separate subsequent visits, participants will perform the same OGTT combined with three stair-climbing bouts lasting 1, 3, and 10 minutes starting 27, 25, and 18 minutes respectively after finishing the drink. Participants performed maximal aerobic capacity (VO2max) using a ramp treadmill test in order to assess the relative intensity of each stairclimbing trial.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Short bouts of moderate intensity stair-climbing
Time frame: 1 hour
Postprandial blood glucose after various durations of stair-climbing
San Diego State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03836495
Energy Expenditure, Glucose Metabolism Disorders
Beirut, Lebanon
View Trial DetailsNCT04430439
Behavior, Behavioral Symptoms
Irvine, California, United States
View Trial DetailsNCT05783752
Glucose Metabolism Disorders, Hyperglycemia
San Diego, California, United States
View Trial DetailsNCT03624569
Bacteremia, Cardiovascular Diseases
Columbus, Ohio, United States
View Trial Details